other material
confidence high
sentiment positive
materiality 0.50
bioAffinity case study shows CyPath Lung avoided invasive biopsy in high-risk nodule patient
bioAffinity Technologies, Inc.
- 71-year-old former smoker with multiple lung nodules received CyPath Lung 'Unlikely Malignancy' result.
- Physician delayed invasive biopsy based on test result; follow-up CT showed nodules resolved or stable.
- CyPath Lung demonstrated 92% sensitivity, 87% specificity, 88% accuracy in clinical study for nodules <20mm.
- Case study underscores noninvasive test's potential to reduce patient anxiety and lower healthcare costs.